Skip to main content

Table 3 Market shares used in the model

From: The economic and fiscal impact of incremental use of cell-based quadrivalent influenza vaccine for the prevention of seasonal influenza among healthcare workers in Italy

 

Year 1 (%)

Year 2 (%)

Year 3 (%)

Market share current market mix (‘As is’ scenario)

 QIVc

10

10

10

 QIVe

90

90

90

 Total

100

100

100

Market share revised market mix (‘To be’ scenario)

 QIVc

20

30

40

 QIVe

80

70

60

 Total

100

100

100